Ludivine Morisset

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Florence Coussy, Rania El Botty, Sophie Château‐Joubert et al. · Science Translational Medicine · 2020 · 148 citations · Full text

Medicine, Cancer Biology, Oncology +13

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance

Élodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd et al. · Nature Communications · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome

Géraldine Mollet, Julien Ratelade, Olivia Boyer et al. · Journal of the American Society of Nephrology · 2009 · 109 citations · Full text

Medicine, Pathobiology, Pathology +17

Renal phenotype of the cystinosis mouse model is dependent upon genetic background

Nathalie Névo, Marie Chol, A Bailleux et al. · Nephrology Dialysis Transplantation · 2009 · 98 citations · Full text

Medicine, Genetics, Nephrology +15

Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities

Sunil Pancholi, Ricardo Ribas, Nikiana Simigdala et al. · Oncogene · 2020 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +17